PRRX1 and Fabry disease: Notably, expression of the activating GNASR201H mutation in Prrx1-Cre mice induces long bone phenotypes reminiscent of FD and impaired mesodermal-derived intramembranous bone formation, both of which could be reversed by blocking Wnt signaling using the PCN inhibitor, LGK974.20